Bharat Biotech announces price of intranasal Covid vaccine
Hyderabad | Vaccine maker Bharat Biotech's intranasal vaccine for Covid-19, the first in the world, is scheduled to be introduced in...
Bharat Biotech
Covaxin booster can neutralise Omicron: Bharat Biotech
New Delhi | Covaxin's booster dose is able to neutralise the vaccine evading Omicron variant of Covid-19, according to a study...
Covaxin gets emergency use approval for children aged 2-18 years
New Delhi | The Hyderabad-based pharma major Bharat Biotech's Covaxin has got the emergency use approval for children in the age group...
Intranasal vaccine trials begin in UP’s Kanpur
Kanpur (Uttar Pradesh) | The phase 2 trials of India's first intranasal vaccine against Covid, being developed by Bharat Biotech in...
India’s first Intranasal Covid vaccine being developed by Bharat Biotech gets nod for Phase 2/3 trials
New Delhi | India's first intranasal vaccine, being developed by Bharat Biotech in collaboration with the Department of Biotechnology and its...
Covaxin effective against Delta Plus variant: ICMR
New Delhi | The domestically developed Covaxin is effective against the Delta plus variant of Covid-19, claims Indian Council of Medical...
Covaxin trials on children likely from next month
Hyderabad | Bharat Biotech may commence paediatric trials of its Covid-19 vaccine Covaxin from June, a senior company official said. The...
India dismisses reports that Covaxin may hamper your travel plans
New Delhi | The Indian government on Saturday dismissed reports claiming that people who are fully vaccinated with Covaxin may not...
Delhi HC declines to stay Covaxin clinical trial on children
New Delhi | The Delhi High Court on Wednesday sought the Centre's response on a plea seeking to set aside the...
Covaxin demonstrates protection against new variants
New Delhi | Peer-review publication, Clinical Infectious Diseases, has noted that Covaxin demonstrates protection against the new Covid-19 variants. Bharat Biotech's...
